tiprankstipranks
Trending News
More News >
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
Advertisement

Silexion Therapeutics (SLXN) Technical Analysis

Compare
197 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
0Neutral
15Bearish
Technical Analysis Consensus
Buy
7Bullish
0Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Silexion Therapeutics’s (SLXN) Moving Averages Convergence Divergence (MACD) indicator is -1.40, suggesting Silexion Therapeutics is a Buy.
Silexion Therapeutics’s (SLXN) 20-Day exponential moving average is 5.45, while Silexion Therapeutics’s (SLXN) share price is $3.5, making it a Sell.
Silexion Therapeutics’s (SLXN) 50-Day exponential moving average is 7.79, while Silexion Therapeutics’s (SLXN) share price is $3.5, making it a Sell.

Silexion Therapeutics (SLXN) Pivot Points

Sep 21, 2025, 12:13 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.30
3.36
3.49
3.55
3.68
3.74
3.87
Fibonacci
3.36
3.44
3.48
3.55
3.63
3.67
3.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Silexion Therapeutics (SLXN) Moving Averages

Sep 21, 2025, 12:13 AM
Period
Simple
Exponential
MA5
3.56Sell
3.75Sell
MA10
4.35Sell
4.37Sell
MA20
5.79Sell
5.45Sell
MA50
8.39Sell
7.79Sell
MA100
11.04Sell
11.18Sell
MA200
16.96Sell
19.47Sell
Silexion Therapeutics’s (SLXN) 10-Day exponential moving average is 4.37, while Silexion Therapeutics’s (SLXN) share price is $3.5, making it a Sell.
Silexion Therapeutics’s (SLXN) 100-Day exponential moving average is 11.18, while Silexion Therapeutics’s (SLXN) share price is $3.5, making it a Sell.
Silexion Therapeutics’s (SLXN) stock price is $3.5 and Silexion Therapeutics’s (SLXN) 50-day simple moving average is 8.39, creating a Sell signal.
Silexion Therapeutics’s (SLXN) stock price is $3.5 and Silexion Therapeutics’s (SLXN) 100-day simple moving average is 11.04, creating a Sell signal.
Silexion Therapeutics’s (SLXN) stock price is $3.5 and Silexion Therapeutics’s (SLXN) 200-day simple moving average is 16.96, creating a Sell signal.

Silexion Therapeutics (SLXN) Technical Indicators

Sep 21, 2025, 12:13 AM
Name
Value
Implied Action
RSI (14)
24.18
Buy
STOCH (9,6)
4.32
Buy
STOCHRSI (14)
4.15
Buy
MACD (12,26)
-1.40
Buy
ADX (14)
11.52
Buy
Williams %R
-97.05
Buy
CCI (14)
-105.25
Buy
ATR (14)
0.83
-
Ultimate Oscillator
20.11
Sell
ROC
-52.19
Sell
Silexion Therapeutics’s (SLXN) Relative Strength Index (RSI) is 24.18, creating a Buy signal.
Silexion Therapeutics’s (SLXN) Trend Strength Indicator (ADX) is 11.52, creating a Buy signal.
Silexion Therapeutics’s (SLXN) Commodity Channel Index (CCI) is -105.25, creating a Buy signal.
Silexion Therapeutics’s (SLXN) Price Rate of Change (ROC) is -52.19, creating a Sell signal.

FAQ

Is SLXN a Buy, Hold, or Sell?
Based on SLXN’s technical indicators, SLXN is a Sell.
    What is SLXN’s RSI (14)?
    SLXN’s RSI (14) is 24.18, which suggests SLXN is a Buy.
      What is SLXN’s MACD?
      SLXN’s MACD is -1.40, which suggests SLXN is a Buy.
        What is SLXN’s 5-day moving average?
        SLXN’s 5-day moving average is 3.56, which suggests SLXN is a Sell.
          What is SLXN’s 20-day moving average?
          SLXN 20-day moving average is 5.79, which suggests SLXN is a Sell.
            What is SLXN’s 50-day moving average?
            SLXN’s 50-day moving average is 8.39, which suggests SLXN is a Sell.
              What is SLXN’s 200-day moving average?
              SLXN’s 200-day moving average is 16.96, which suggests SLXN is a Sell.
                What is SLXN’s Williams % R (14)?
                SLXN’s Williams % R (14) is -97.05, which suggests SLXN is a Buy.
                  What is SLXN’s CCI (14)?
                  SLXN’s CCI (14) is -105.25, which suggests SLXN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis